Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11276
PUT
Schwab US Broad Market ETF
SCHB
$45.2B
| $111K | ﹤0.01% |
4,900
-5,900
| -55% | -$135K |
2022 Q3
9 quarters
|
|
|
OS
11277
PUT
DELISTED
OneStream Inc
OS
| $111K | ﹤0.01% |
3,900
-1,300
| -25% | -$39.9K |
2024 Q3
1 quarter
|
|
11278
CPI Aerostructures
CVU
$67.6M
| $111K | ﹤0.01% |
27,452
-6,692
| -20% | -$23.6K |
2022 Q4
8 quarters
|
|
11279
The ONE Group
STKS
$47.5M
| $111K | ﹤0.01% |
38,335
-30,483
| -44% | -$101K |
2024 Q1
3 quarters
|
|
11280
CVD Equipment Corp
CVV
$29.1M
| $111K | ﹤0.01% |
25,258
-15,704
| -38% | -$52K |
2023 Q4
4 quarters
|
|
11281
CALL
United States 12 Month Natural Gas Fund
UNL
$15.6M
| $111K | ﹤0.01% |
13,600
+13,400
| +6,700% | +$99.5K |
2024 Q2
2 quarters
|
|
|
OPLN
11282
CALL
Openlane
OPLN
$4.25B
| $111K | ﹤0.01% |
+5,600
| New | +$103K |
2024 Q4
0 quarters
|
|
11283
PUT
Westlake Chemical Partners
WLKP
$754M
| $111K | ﹤0.01% |
4,800
-700
| -13% | -$16.1K |
2022 Q3
9 quarters
|
|
11284
CALL
Legacy Housing
LEGH
$673M
| $111K | ﹤0.01% |
4,500
-23,900
| -84% | -$618K |
2022 Q4
8 quarters
|
|
11285
PUT
Power Integrations
POWI
$2.87B
| $111K | ﹤0.01% |
1,800
-18,600
| -91% | -$1.18M |
2020 Q1
19 quarters
|
|
11286
CALL
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$292M
| $111K | ﹤0.01% |
+6,200
| New | +$123K |
2024 Q4
0 quarters
|
|
11287
PUT
Agilon Health
AGL
$1.44B
| $111K | ﹤0.01% |
2,336
-3,656
| -61% | -$221K |
2021 Q3
13 quarters
|
|
11288
CALL
Federal Signal
FSS
$6.98B
| $111K | ﹤0.01% |
1,200
-5,600
| -82% | -$515K |
2022 Q4
8 quarters
|
|
11289
CALL
Gossamer Bio
GOSS
$62.3M
| $111K | ﹤0.01% |
1,531
+347
| +29% | +$23.8K |
2020 Q4
16 quarters
|
|
11290
Teucrium Corn Fund
CORN
$130M
| $111K | ﹤0.01% |
5,898
-11,117
| -65% | -$202K |
2023 Q1
7 quarters
|
|
11291
PUT
Old National Bancorp
ONB
$9.34B
| $111K | ﹤0.01% |
5,100
+3,700
| +264% | +$77K |
2022 Q4
8 quarters
|
|
|
OGG
11292
CALL
Osisko Gold Group
OGG
$844M
| $111K | ﹤0.01% |
67,900
+32,700
| +93% | +$61.1K |
2022 Q4
8 quarters
|
|
11293
Neuraxis
NRXS
$85.8M
| $111K | ﹤0.01% |
+47,094
| New | +$132K |
2024 Q4
0 quarters
|
|
11294
Clene
CLNN
$55.7M
| $111K | ﹤0.01% |
+20,835
| New | +$105K |
2024 Q4
0 quarters
|
|
11295
PUT
Sylvamo
SLVM
$1.26B
| $111K | ﹤0.01% |
1,400
-8,800
| -86% | -$759K |
2021 Q4
12 quarters
|
|
11296
CALL
Schwab 1000 Index ETF
SCHK
$5.83B
| $110K | ﹤0.01% |
+3,900
| New | +$111K |
2024 Q4
0 quarters
|
|
11297
PUT
Monte Rosa Therapeutics
GLUE
$868M
| $110K | ﹤0.01% |
15,900
-15,300
| -49% | -$115K |
2023 Q4
4 quarters
|
|
|
PPT
11298
Franklin Premier Income Trust
PPT
$313M
| $110K | ﹤0.01% |
+30,994
| New | +$112K |
2024 Q4
0 quarters
|
|
11299
CALL
First Trust STOXX European Select Dividend Income Fund
FDD
$866M
| $110K | ﹤0.01% |
+9,800
| New | +$115K |
2024 Q4
0 quarters
|
|
11300
PUT
HighPeak Energy
HPK
$1.08B
| $110K | ﹤0.01% |
7,500
-23,000
| -75% | -$330K |
2023 Q2
6 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.